×
About 95,678 results

ALLMedicine™ Pneumonia Center

Research & Reviews  43,393 results

Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Ac...
https://doi.org/10.1007/s40265-020-01443-4
Drugs Zhanel GG, Deng C et. al.

Nov 28th, 2020 - Lefamulin is a novel oral and intravenous (IV) pleuromutilin developed as a twice-daily treatment for community-acquired bacterial pneumonia (CABP). It is a semi-synthetic pleuromutilin with a chemical structure that contains a tricyclic core of f...

Safety considerations of current drug treatment strategies for nosocomial pneumonia.
https://doi.org/10.1080/14740338.2021.1857362
Expert Opinion on Drug Safety; Ceccato A, Di Giannatale P et. al.

Nov 27th, 2020 - Introduction: Nosocomial pneumonia unfortunately remains a frequent event for which appropriate antibiotic treatment is central to improving outcomes. Physicians must choose an early and appropriate empirical treatment, basing their decision on th...

Pneumatocele formation in a fatal adult pneumonia patient coinfected with Streptococcus...
https://doi.org/10.1186/s12879-020-05595-2
BMC Infectious Diseases; Sano M, Shimamoto A et. al.

Nov 27th, 2020 - A pneumatocele is a transient thin-walled lesion and rare complication in adult pneumonia. A variety of infectious pathogens have been reported in children with pneumatoceles. We report the first case of adult pneumonia with pneumatocele formation...

Nocardiosis in glomerular disease patients with immunosuppressive therapy.
https://doi.org/10.1186/s12882-020-02179-9
BMC Nephrology; Han Y, Huang Z et. al.

Nov 27th, 2020 - Glomerular disease patients have a high risk of infection, which contributes to the progression of disease per se and mortality, especially in those with long-term use of glucocorticoids and (or) immunosuppressive agents. Cases of sporadic nocardi...

The differences of clinical characteristics and outcomes between imported and local pat...
https://doi.org/10.1186/s12931-020-01551-5
Respiratory Research; Wang C, Zhou L et. al.

Nov 27th, 2020 - The clinical characteristics and outcomes of the 2019 novel coronavirus (COVID-19) pneumonia are different in Hubei compared to other regions in China. But there are few comparative studies on the differences between imported and local patients wh...

see more →

Guidelines  223 results

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evide...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472403
Military Medical Research; Jin YH, Zhan QY et. al.

Sep 5th, 2020 - The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guideli...

ACR Appropriateness Criteria® Pneumonia in the Immunocompetent Child.
https://doi.org/10.1016/j.jacr.2020.01.033
Journal of the American College of Radiology : JACR; , Chan SS et. al.

May 5th, 2020 - Pneumonia is one of the most common acute infections and the single greatest infectious cause of death in children worldwide. In uncomplicated, community-acquired pneumonia in immunocompetent patients, the diagnosis is clinical and imaging has no ...

Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
http://www.aginganddisease.org/EN/10.14336/AD.2020.0228
Aging and Disease;

Mar 12th, 2020 - A coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19) outbreak in Wuhan, China. Preventing and reversing the cytokine storm may be the key to save the patients with severe COVID-19 pneumonia. Mesenchymal stem cells (MSCs) hav...

COVID-19 and the cardiovascular system
https://www.nature.com/articles/s41569-020-0360-5
Nature Reviews Cardiology; Zheng YY,et al

Mar 4th, 2020 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through ACE2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, while also causing acute myocardial injury and chronic damage to the cardiovascula...

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
https://www.sciencedirect.com/science/article/pii/S1684118220300402
Journal of Microbiology, Immunology and Infection;

Mar 3rd, 2020 - Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019 novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 75,0...

see more →

Drugs  1,417 results see all →

Clinicaltrials.gov  47,143 results

Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Ac...
https://doi.org/10.1007/s40265-020-01443-4
Drugs Zhanel GG, Deng C et. al.

Nov 28th, 2020 - Lefamulin is a novel oral and intravenous (IV) pleuromutilin developed as a twice-daily treatment for community-acquired bacterial pneumonia (CABP). It is a semi-synthetic pleuromutilin with a chemical structure that contains a tricyclic core of f...

Safety considerations of current drug treatment strategies for nosocomial pneumonia.
https://doi.org/10.1080/14740338.2021.1857362
Expert Opinion on Drug Safety; Ceccato A, Di Giannatale P et. al.

Nov 27th, 2020 - Introduction: Nosocomial pneumonia unfortunately remains a frequent event for which appropriate antibiotic treatment is central to improving outcomes. Physicians must choose an early and appropriate empirical treatment, basing their decision on th...

Pneumatocele formation in a fatal adult pneumonia patient coinfected with Streptococcus...
https://doi.org/10.1186/s12879-020-05595-2
BMC Infectious Diseases; Sano M, Shimamoto A et. al.

Nov 27th, 2020 - A pneumatocele is a transient thin-walled lesion and rare complication in adult pneumonia. A variety of infectious pathogens have been reported in children with pneumatoceles. We report the first case of adult pneumonia with pneumatocele formation...

Nocardiosis in glomerular disease patients with immunosuppressive therapy.
https://doi.org/10.1186/s12882-020-02179-9
BMC Nephrology; Han Y, Huang Z et. al.

Nov 27th, 2020 - Glomerular disease patients have a high risk of infection, which contributes to the progression of disease per se and mortality, especially in those with long-term use of glucocorticoids and (or) immunosuppressive agents. Cases of sporadic nocardi...

The differences of clinical characteristics and outcomes between imported and local pat...
https://doi.org/10.1186/s12931-020-01551-5
Respiratory Research; Wang C, Zhou L et. al.

Nov 27th, 2020 - The clinical characteristics and outcomes of the 2019 novel coronavirus (COVID-19) pneumonia are different in Hubei compared to other regions in China. But there are few comparative studies on the differences between imported and local patients wh...

see more →

News  3,371 results

Plasma From Recovered Patients Shows Little Benefit in Those Hospitalized With COVID-19: Study
https://www.medscape.com/viewarticle/941566

Nov 24th, 2020 - (Reuters) - Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in Argentina. The therapy know as con...

COVID-19: The Latest NICE Guidance
https://www.medscape.com/viewarticle/927912

Nov 23rd, 2020 - Editor's note, 24 November 2020: This article was updated to include the latest guidance. Patients with COVID-19 pneumonia managed in community settings Assess the risks of VTE and bleeding. Consider pharmacological prophylaxis if the risk of VTE ...

Many Patients With Type 2 MI Don't Get Cardiologist Evaluation
https://www.medscape.com/viewarticle/941462

Nov 22nd, 2020 - Perhaps 40% of hospitalized patients with type 2 myocardial infarction (MI) are not evaluated by a cardiologist at the same admission, suggests a study based on experience over several years at a major medical center. Such patients may be short-ch...

Metapneumovirus Infections Clinically Indistinguishable From Flu, RSV
https://www.staging.medscape.com/viewarticle/941323

Nov 18th, 2020 - The all-consuming news about SARS-CoV-2 and COVID-19 has overshadowed other viral pathogens that are the cause of severe or fatal lower respiratory infections (LRI) including human metapneumovirus (HMPV). "MPV is really a leading cause of LRI not ...

Metapneumovirus Infections Clinically Indistinguishable From Flu, RSV
https://www.medscape.com/viewarticle/941323

Nov 18th, 2020 - The all-consuming news about SARS-CoV-2 and COVID-19 has overshadowed other viral pathogens that are the cause of severe or fatal lower respiratory infections (LRI) including human metapneumovirus (HMPV). "MPV is really a leading cause of LRI not ...

see more →

Patient Education  131 results see all →